Health  Vol.6 No.12 , June 2014
A Study on Lung Cancer in Jianghan Plain
Abstract: This study was to investigate the epidemiology of lung cancer in Jianghan Plain, providing scientific basis for prevention and treatment of lung cancer. Pathology and clinical data of 1290 patients diagnosed lung cancer from the largest hospital in Jianghan Plain were collected and analyzed. Results found that the lung cancer incidence increased gradually from the age of 40 and at the peak during 61 to 70 years old; the male to female ratio was 2.45:1; Smoking patients were 841 cases, accounting for 65.2% of all cases. Smoke index > 400 was 771 cases accounting for 91.7 percent of smokers and smoking index < 400 was 70 cases accounting for 8.3% of smoking patients. 93.6% of the patients were to start smoking at a young age. The rate of patient pathological cytology diagnosed by fiberoptic bronchoscopy was 31.8%, which showed that it was an important diagnostic method for lung cancer. The main reason for smoking is to break up the monotony and although many patients know nicotine, carbon monoxide is the main smoking harmful substances and smoking may cause lung cancer; not many people can take the initiative to quit smoking. It also showed that squamous cell carcinoma was the main type in smoking patients, while adeno-carcinoma in non-smoking patients. The comprehensive epidemiological analysis suggested that smoking is an important factor in causing lung cancer, smoking cessation education and regular medical examinations to strengthen the prevention of lung cancer have a positive meaning to their family members.
Cite this paper: Zhang, K. , Li, M. , Zhang, Y. and Peng, X. (2014) A Study on Lung Cancer in Jianghan Plain. Health, 6, 1340-1344. doi: 10.4236/health.2014.612164.

[1]   Xiao, D., Wang, C., Chen, H. and Hajek, P. (2013) Making Hospitals in China Smoke-Free: A Prospective Study of Implementing the New Standard. Nicotine & Tobacco Research, 15, 2076-2080.
Eriksen, M., Mackay, J. and Ross, H. (2013) The Tobcco Atlas. 4th Edition.

[2]   Dusek, L., Muzík, J., Gelnarová, E., Fínek, J., Vyzula, R. and Abrahámová, J. (2010) Cancer Incidence and Mortality in the Czech Republic. Klinická Onkologie, 23, 311-324.

[3]   Lin, M.H., Huang, S.J., Shih, W.M., Wang, P.Y., Lin, L.H. and Hsu, H.C. (2013) Effects of an Anti-Smoking Program to Prevent Lung Cancer among Urban Aboriginals in Taiwan. Asian Pacific Journal of Cancer PRevention, 14, 6451-6457.

[4]   Shaykhiev, R. and Crystal, R.G. (2013) Basal Cell Origins of Smoking-Induced Airway Epithelial Disorders. Cell Cycle, 13, 311-324.

[5]   Munshi, V. and McMahon, P. (2013) Importance of Smoking Cessation in a Lung Cancer Screening Program. Current Surgery Reports, 1, 4.

[6]   Gordon, J.S., Lichtenstein, E., Severson, H.H. and Andrews, J.A. (2006) Tobacco Cessation in Dental Settings: Research Findings and Future Directions. Drug and Alcohol Review, 25, 27-37.

[7]   Bullen, C. (2008) Impact of Tobacco Smoking and Smoking Cessation on Cardiovascular Risk and Disease. Expert Review of Cardiovascular Therapy, 6, 883-895.

[8]   Savant, S.C., Hegde-Shetiya, S., Agarwal, D., Shirhatti, R. and Shetty, D. (2006) Effectiveness of Individual and Group Counseling for Cessation of Tobacco Habit amongst Industrial Workers in Pimpri, Pune—An Interventional Study. Asian Pacific journal of Cancer Prevention, 14, 1133-1139.

[9]   Singh, N. and Behera, D. (2013) Lung Cancer Epidemiology and Clinical Profile in North India: Similarities and Differences with Other Geographical Regions of India. Indian Journal of Cancer, 50, 291.

[10]   Chan, C.W., Richardson, A. and Richardson, J. (2013) An Investigation of a Symptom Cluster in Chinese Patients with Lung Cancer Receiving Radiotherapy. Contemporary Nurse, 45, 164-173.

[11]   Rezaei, M.K., Nolan, N.J. and Schwartz, A.M. (2013) Surgical Pathology of Lung Cancer. Seminars in Respiratory and Critical Care Medicine, 34,770-786.

[12]   Garg, B., Sood, N., Sidhu, U.P. and Malhotra, V. (2013) Role of Fiberoptic Bronchoscopy and Utility of Bronchial Washings and Brushings in the Diagnosis of Lung Diseasesr. Indian Journal of Chest Disease and Allied Science, 55, 145-148.

[13]   Søgaard, M., Thomsen, R.W., Bossen, K.S., Sørensen, H.T. and Nørgaard, M. (2013) The Impact of Comorbidity on Cancer Survival: A Review. Journal of Clinical Epidemiology, 5, 3-29.

[14]   Horita, N., Miyazawa, N., Morita, S., Kojima, R., Kimura, N., Kaneko, T. and Ishigatsubo, Y. (2013) Preoperative Chemotherapy Is Effective for Stage III Resectable Non-Small-Cell Lung Cancer: Metaanalysis of 16 Trials. Clinical Lung Cancer, 14, 488-494.

[15]   Lin, G., Li, Y., Chen, S. and Jiang, H. (2013) Integrated Chinese-Western Therapy versus Western Therapy Alone on Survival Rate in Patients with Non-Small-Cell Lung Cancer at Middle-Late Stage. Journal of Traditional Chinese Medicine, 33, 433-438.